Concepedia

Author

Hiroyoshi Horikoshi

Daiichi-Sankyo (Japan)

Also Known As

A. Kot’átková, H Horikoshi, H. HORIKOSHI, H. Horikoshi, HIROYOSHI HORIKOSHI, Hiroyoshi HORIKOSHI, Hiroyoshi Horikoshi

76

Publications

5.6K

Citations

26

H-Index

72

Concepts

All Affiliations

Daiichi-Sankyo (Japan)Biomedical Research Laboratories (United States)The University of TokyoDaiichi Sankyo (Germany)University of California San Diego
HH

About

Hiroyoshi Horikoshi is an author at Daiichi-Sankyo (Japan) specializing in medicine, pharmacology, and physiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

20

27

4.1K

2

Health Sciences

14

14

3.7K

3

Natural Sciences

6

6

137

4

Public Health

2

2

44

5

Engineering

1

1

87

Hiroyoshi Horikoshi

×

38

Publications

5.2K

Citations

25

H-Index

YearCitations

Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1

Hiroyuki Tamemoto, Takashi Kadowaki, Kazuyuki Tobe,

Nature

1994

1.1K

Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.

Akira Okuno, Hiroyuki Tamemoto, Kazuuki TOBE,

Journal of Clinical Investigation

1998

997

Characterization of New Oral Antidiabetic Agent CS-045: Studies in KK and <i>ob/ob</i> Mice and Zucker Fatty Rats

Toshihiko Fujiwara, Shinji Yoshioka, Takao Yoshioka,

Diabetes

1988

455

Angptl3 regulates lipid metabolism in mice

Ryuta Koishi, Mitsuru Ono, Mitsuru Shimamura,

Nature Genetics

2002

416

Effect of troglitazone on body fat distribution in type 2 diabetic patients.

Yuki Mori, Yūichi Murakawa, Keisuke Okada,

Diabetes Care

1999

280

Studies on hindered phenols and analogs. 1. Hypolipidemic and hypoglycemic agents with ability to inhibit lipid peroxidation

Takao Yoshioka, Takashi Fujita, Tsutomu Kanai,

Journal of Medicinal Chemistry

1989

220

Tumor necrosis factor-alpha- and hyperglycemia-induced insulin resistance. Evidence for different mechanisms and different effects on insulin signaling.

G Kroder, Birgit Bossenmaier, Monika Kellerer,

Journal of Clinical Investigation

1996

217

Impairment of Insulin Signaling in Human Skeletal Muscle Cells by Co-Culture With Human Adipocytes

Daniela Dietze, Marlis Koenen, K Röhrig,

Diabetes

2002

182

Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats

Takuya Fujiwara, S. Yoshioka, Tomohisa Yoshioka,

Diabetes

1988

158

Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in - mice

Toshihiko Fujiwara, Mikiyo Wada, Kuniaki Fukuda,

Metabolism

1991

116

Page 1